Prof. Dr. Monika Kirsch

Professorin für Angewandte Gesundheits- und Pflegewissenschaften
Fachliche Beratung zum Master-Studiengang Advanced Practice in Healthcare

Erzbergerstraße 121, Raum F372

Wissenschaftliche Ausbildung

2010 ‑ 2014

Wissenschaftliche Mitarbeiterin und Promotion

am Institut für Pflegewissenschaft, Universität Basel

2006 ‑ 2009

Studium der Pflegewissenschaft am Institut für Pflegewissenschaft,

Universität Basel

Berufliche Tätigkeiten

seit Januar 2022

Professorin für Angewandte Gesundheits- und Pflegewissenschaften, DHBW Karlsruhe

2021

Elternzeit

2015 ‑ 2021

Pflegeexpertin, Advanced Practice Nurse (APN) Schmerztherapie

Abteilung Schmerztherapie am Department für Anästhesiologie, Universitätsspital Basel

2010 ‑ 2015

Pflegeexpertin (APN) Hämatologie

Zellersatzambulatorium & Tagesklinik, Stammzelltransplantationszentrum,

Universitätsspital Basel

2005 ‑ 2010

Pflegefachfrau Innere Medizin/Onkologie und Isolierstation,

Stammzelltransplantationszentrum, Universitätsspital Basel

2003 ‑ 2004

Pflegefachfrau Chrischona Klinik, Bürgerspital Basel

2000 ‑ 2003

Ausbildung zur examinierten Krankenschwester

Krankenpflegeschule Kreiskrankenhaus Dormagen

Lehrgebiete

  • Pflegetheorie und Forschung
  • Erweiterte Pflegepraxis
  • Onkologische Pflege und Schmerztherapie
  • Pflegeassessment und -diagnostik

Forschungsgebiete

  • Patientenselbstmanagement
  • Symptommanagement
  • Praxisentwicklung in der Pflege

Veröffentlichungen

  • Erweiterte Suche öffnen

  • 2021

  • Leuthold, Nicolas; Cattaneo, Marco; Halter, Joerg P.; Hügli, Claudia; Kirsch, Monika; Petropoulou, Anna; Erlanger, Tobias E.; Gerull, Sabine; Passweg, Jakob; O'Meara Stern; Alix (2021): Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient's perspective?. In: Support Care Cancer 6 (Jun;29(6)), S. 3129-3135. DOI: 10.1007/s00520-020-05816-z
  • 2020

  • Emsden, Christian; Barandun Schäfer, Ursi; Denhaerynck, Kris; Grossmann, Florian; Frei, Irena Anna; Kirsch, Monika (2020): Validating a pain assessment tool in heterogeneous ICU patients: Is it possible?. In: Nursing in Critical Care 1 (25), S. 8-15. DOI: 10.1111/nicc.12469
  • Kiesewetter, I.; Pilge, S.; Kirsch, Monika; Emsden, Christian (2020): Zusammenfassung von zwei Studien zur Validierung des Critical Care Pain Observation Tool (CPOT) zur Beurteilung von Schmerzen bei nichtäußerungsfähigen Intensivpatienten. In: Anaesthesist 7 (69), S. 487-488. DOI: 10.1007/s00101-020-00799-2
  • Kirsch, Monika; Ries Gisler, Tobias; Schneider, Tobias (2020): Neuropathischer Schmerz: Welche Medikamente zeigen die beste Wirksamkeit?. In: Anästhesie Journal 2 (3), S. 29-31

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • 2019

  • Dobbels, Fabienne; Denhaerynck, Kris; Klem, Mary Lou; Sereika, Susan M.; Geest, Sabina de; Simone, Paolo de; B-SERIOUS consortium, Berben, Lut; Binet, Isabelle; Burkhalter, Hanna; Drent, Gerda; Duerinckx, Nathalie; Engberg, Sandra J.; Glass, Tracy; Gordon, Elisa; Kirsch, Monika; Kugler, Christiane; Lerret, Stacee; Rossmeissl, Anja; Russell, Cynthia; Schmidt-Trucksäss, Arno; Almeida, Samira Scalso de (2019): Correlates and outcomes of alcohol use after single solid organ transplantation: A systematic review and meta-analysis 1 (33), S. 17-28. DOI: 10.1016/j.trre.2018.09.003
  • Kirsch, Monika (2019): Kryotherapie der Hände und Füsse kann Neuropathien unter Paclitexal effektiv vermindern. In: Onkologische Pflege (3), S. 28-29

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Kirsch, Monika (2019): Buchbesprechung. Edukation in der Pflege. In: Onkologiepflege (2019/1)

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Valenta, Sabine; Kirsch, Monika (2019): Wie Familienangehörige von Patienten mit Krebs Symptome zu Hause bewältigen: Research Flash einer Systematischen Literatursuche. In: Onkologische Pflege (2), S. 34-35

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • 2018

  • Gresch, Barbara; Kirsch, Monika (2018): Medikamentenadhärenz in der Onkologie. Haben wir ein Problem? (2018/3), S. 41-47

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Kirsch, Monika; Tichelli, André (2018) : Adhärenz bei Stammzelltransplantation In: Ayuk, Francis; Kröger, Nicolaus; Tichelli, André (Hg.): Langzeitnachsorge von Patienten nach allogener Blutstammzelltransplantation: Bremen: Uni-Med Verlag AG, S. 146-150

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Naegele, Matthias; Kirsch, Monika; Ihorst, Gabriele; Fierz, Katharina; Engelhardt, Monika; Geest, Sabina de (2018): Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study. In: Supportive Care in Cancer 3 (26), S. 833-841. DOI: 10.1007/s00520-017-3897-z
  • Senft, Yuliya; Kirsch, Monika; Denhaerynck Kris; Dobbels, Fabienne; Helmy Remon; Russell Cynthia L.; Berben Lut; Geest, Sabina de; BRIGHT study team (2018): Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. In: European journal of cardiovascular nursing 17 (4), S. 356-367. DOI: 10.1177/1474515117747577

    DOI: http://www.ncbi.nlm.nih.gov/pubmed/29231747 

    Abstract: BACKGROUND As medication non-adherence is a major risk factor for poor post-transplant outcomes, we explored how adherence is assessed, enhanced and integrated across the transplant continuum. AIM The aim of this study was to study practice patterns regarding pre- and post-transplant medication adherence assessment and interventions in international heart transplant centres. METHODS We used data from the Building Research Initiative Group: chronic illness management and adherence in heart transplantation (BRIGHT) study, a cross-sectional study conducted in 36 heart transplant centres in 11 countries. On a 27-item questionnaire, 100 clinicians (range one to five per centre) reported their practice patterns regarding adherence assessment and intervention strategies pre-transplant, immediately post-transplant, less than one year, and one or more year post-transplant. Educational/cognitive, counselling/behavioural and psychosocial/affective strategies were assessed. Clinicians' responses (intervention present vs. absent; or incongruence in reporting intervention) were aggregated at the centre level. RESULTS The adherence assessment method most commonly used along the transplant continuum was questioning patients (range 75-88.9%). Pre-transplant, all three categories of intervention strategy were applied. Providing reading materials (82.9%) or instructions (68.6%), involving family or support persons in education (91.4%), and establishing partnership (91.4%) were used most frequently. Post-transplant, strategies closely resembled those employed pre-transplant. Training patients (during recovery) and cueing were more often applied during hospitalisation (74.3%). After the first year post-transplant, except for motivational interviewing (25.7-28.6%), the number of strategies decreased. CONCLUSIONS Across the transplant continuum, diverse adherence interventions are implemented; however, post-transplant, the frequency of adherence interventions decreases. Therefore, increased investment is necessary in long-term adherence interventions.

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • 2017

  • Gerull, Sabine; Denhaerynck, Kris; Chalandon, Yves; Halter, Joerg P.; Kirsch, Monika; Kiss, Alexander; Schanz, Urs; Vu, Diem Lan; Geest, Sabina de; Passweg, Jakob (2017): Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study. In: Bone marrow transplantation 52 (12), S. 1686-1688. DOI: 10.1038/bmt.2017.204
  • Gresch, Barbara; Kirsch, Monika; Fierz, Katharina; Halter, Joerg P.; Nair, Gayathri; Denhaerynck Kris; Geest, Sabina de (2017): Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study. In: Bone marrow transplantation 52 (2), S. 304-306. DOI: 10.1038/bmt.2016.262
  • Gresch, Barbara; Gassmann, Cath.; Kirsch, Monika (2017): Effektivität von oraler Tumortherapie. Medikamentenadhärenz von zentraler Bedeutung. In: info@onkologie (2017/7), S. 24-27

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Kirsch, Monika; Ruppen, Wilhelm (2017): Rote Karte für den Schmerz. In: Basler Zeitung (28.01.2017)

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Kirsch, Monika (2017): Research flash. Pflegerische Schmerzberatung ist effektiv. In: Onkologiepflege (2017/3)

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Kirsch, Monika (2017): Buchbesprechung. Gesichter des Schmerzes. In: Onkologiepflege (2017/3)

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML

  • Valenta, Sabine; Geest, Sabina de; Fierz, Katharina; Beckmann, Sonja; Halter, Joerg P.; Schanz, Urs; Nair, Gayathri; Kirsch, Monika (2017): Perception of late effects among long-term survivors after haematopoietic stem cell transplantation. Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study. In: Eur J Oncol Nurs, S. 17-27. DOI: 10.1016/j.ejon.2017.01.003
  • 2016

  • Duerinckx, Nathalie; Burkhalter, Hanna; Engberg, Sandra J.; Kirsch, Monika; Klem, Mary-Lou; Sereika, Susan M.; Simone, Paolo de; Geest, Sabina de; Dobbels, Fabienne (2016): Correlates and Outcomes of Posttransplant Smoking in Solid Organ Transplant Recipients: A Systematic Literature Review and Meta-Analysis. In: Transplantation 100 (11), S. 2252-2263. DOI: 10.1097/tp.0000000000001335

    DOI: http://www.ncbi.nlm.nih.gov/pubmed/27479162 

    Abstract: BACKGROUND Despite smoking being an absolute or relative contraindication for transplantation, about 11% to 40% of all patients continue or resume smoking posttransplant. This systematic review with meta-analysis investigated the correlates and outcomes associated with smoking after solid organ transplantation. METHODS We searched PubMed, EMBASE, CINAHL, and PsycINFO from inception until January 2016, using state-of-the art methodology. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were computed for correlates/outcomes investigated 5 times or more. RESULTS Seventy-three studies (43 in kidney, 17 in heart, 12 in liver, 1 in lung transplantation) investigated 95 correlates and 24 outcomes, of which 6 correlates and 4 outcomes could be included in the meta-analysis. The odds of smoking posttransplant were 1.33 times higher in men (95% CI, 1.12-1.57). Older individuals were significantly less likely to smoke (OR, 0.48; 95% CI, 0.38-0.62), as were patients with a higher body mass index (OR, 0.68; 95% CI, 0.52-0.89). Hypertension (OR, 1.16; 95% CI, 0.77-1.75), diabetes mellitus (OR, 0.52; 95% CI, 0.15-1.78), and having a history of cardiovascular disease (OR, 0.92; 95% CI, 0.77-1.09) were not significant correlates. Posttransplant smokers had higher odds of newly developed posttransplant cardiovascular disease (OR, 1.41; 95% CI, 1.02-1.95), nonskin malignancies (OR, 2.58; 95% CI, 1.26-5.29), a shorter patient survival time (OR, 0.59; 95% CI, 0.44-0.79), and higher odds of mortality (OR, 1.74; 95% CI, 1.21-2.48). CONCLUSIONS Posttransplant smoking is associated with poor outcomes. Our results might help clinicians to understand which patients are more likely to smoke posttransplant, guide interventional approaches, and provide recommendations for future research.

    Export-Dateien: Citavi Endnote RIS ISI BibTeX WordXML